Kronox directors endorse Rs 157.27 Indo Borax open offer

Kronox Lab Sciences Limited’s independent directors unanimously found Indo Borax’s Rs 157.27-per-share cash open offer fair and reasonable on November 2, 2026, citing its equivalence to the preceding 60-trading-day volume weighted average price and its maximum consideration of Rs 150.50739 crore for 25.79% of voting capital.

Why did Kronox directors endorse the open offer?

Kronox’s Committee of Independent Directors, or IDC, concluded that the Rs 157.27 offer price complied with applicable Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and was fair and reasonable. The three-member IDC made the recommendation on November 2, 2026 after reviewing the August 20 public announcement, August 28 detailed public statement, September 4 draft letter of offer and October 29 letter of offer.

The recommendation was unanimous among chairperson Anuradha Suneet Maheshwari and members Amit Kumar Sharma and Dhananjay Tapasvi, all of whom attended the November 2 meeting. Kronox said the three were non-executive independent directors, held no Kronox equity shares or other securities, and had no relationship with Kronox other than their board and committee roles.

The IDC recorded no independent adviser and no other matter to highlight in its November 2 statement. Its conclusion was limited to the Rs 157.27 price under the takeover regulations, while public shareholders retain the option to tender shares or continue as Kronox shareholders.

What are the terms of Indo Borax’s offer for Kronox?

Indo Borax and Chemicals Limited, with Zenrock Chemicals Private Limited acting in concert, is offering cash of Rs 157.27 per share for up to 95.70 lakh fully paid Kronox equity shares. The offer represents 25.79% of Kronox voting share capital and has maximum consideration of Rs 150.50739 crore.

The offer is being made under Regulations 3(1) and 4 of the takeover regulations, with IIFL Capital Services Limited as manager to the offer. Each Kronox equity share has a face value of Rs 10, but the offer consideration is based on the Rs 157.27 price paid for shares tendered and accepted.

Kronox said the 25.79% offer size is below the usual 26.00% minimum because public shareholders held only 95.70 lakh shares at the relevant reference point. That holding represented 25.79% of voting share capital as of the 10th working day from closure of the tendering period, so the offer covers the disclosed public shareholding available then.

How does Kronox’s offer price compare with market and deal benchmarks?

The Rs 157.27 offer price equals the volume weighted average price, or VWAP, for the 60 trading days immediately before the August 20, 2026 public announcement. The IDC said the National Stock Exchange of India, or NSE, recorded the highest trading volume in Kronox shares during that period, and that the shares were frequently traded under the takeover regulations.

The offer is Rs 54.05 per share above the Rs 103.22 price under the August 20 share purchase agreement, as amended on October 22. The IDC identified Rs 103.22 as the highest negotiated price for an acquisition under the agreement that triggered the obligation to make the open offer.

A second benchmark includes transition-support consultancy fees payable by Kronox to each seller. The filing said this Regulation 8(7) figure was Rs 105.87 per share, making the Rs 157.27 offer Rs 51.40 higher than the inclusive transaction value.

The comparison shows that the offer matches the market-derived 60-day VWAP but exceeds both disclosed negotiated-price measures. The IDC said the Rs 157.27 price met Regulations 8(1), 8(2) and 8(7), without expressing a view on future Kronox market prices or the number of shares eventually tendered.

Are Kronox’s independent directors free of ties to the offer parties?

Kronox disclosed that none of the three IDC members owned its equity shares or other securities, apart from serving as independent directors and committee members or chairperson. None traded Kronox securities during the 12 months before the August 20, 2026 public announcement or between that announcement and the November 2 recommendation.

The IDC also stated that none of its members was a director of Indo Borax or Zenrock, held shares or other securities in either entity, or had another contract or relationship with either party. These disclosures accompanied the committee’s Rs 157.27 recommendation for an offer worth up to Rs 150.50739 crore.

The filing’s no-trading disclosure for the acquirer-related section repeats wording referring to Kronox securities. The reported facts are that the committee disclosed no ownership, directorship or contractual relationship involving Indo Borax or Zenrock, and the recommendation was unanimously approved by all three members.

What should Kronox shareholders consider before tendering?

Kronox shareholders may tender their shares at Rs 157.27 or remain public shareholders, according to the November 2 IDC statement. The offer seeks up to 95.70 lakh shares, equal to the 25.79% public shareholding disclosed at the 10th-working-day reference point.

The IDC advised shareholders to independently evaluate the open offer and Kronox’s market performance before deciding. Its fairness conclusion was based on the offer documents and the price benchmarks of Rs 157.27, Rs 103.22 and Rs 105.87, rather than on individual shareholders’ tax position, objectives or holding period.

The formal documents include the August 20 public announcement, August 28 detailed public statement, September 4 draft letter of offer and October 29 letter of offer. Kronox said the IDC recommendation was published on November 3, 2026 in Financial Express, Jansatta, Navshakti and Loksatta-Jansatta.

Conclusion

Kronox’s independent directors have unanimously endorsed the Rs 157.27 cash offer from Indo Borax as fair and reasonable under the takeover regulations. Their stated evidence was that the price equalled the 60-trading-day VWAP before August 20, 2026 and was above the Rs 103.22 negotiated purchase price as well as the Rs 105.87 figure including specified consultancy fees.

The next disclosed matter is the tender process under the October 29, 2026 letter of offer, under which shareholders may tender or retain their Kronox shares. Participation levels will determine how much of the 95.70 lakh-share, Rs 150.50739 crore offer is accepted, while the filing does not state an expected acceptance level.